Showing results (71-80 of 109) with videos related to
Sort By:
Pageof 11
The British Journal of Nutrition|November 17, 2020
<i>FNDC5</i> polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver diseaseFeng Gao, Kenneth I Zheng, Pei-Wu Zhu, et al.Plos One|June 10, 2015
Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver ResectionSha Huang, Gui-Qian Huang, Gui-Qi Zhu, et al.BMC Gastroenterology|May 8, 2020
Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?Min Zhang, Su Lin, Ming-Fang Wang, et al.Frontiers in Medicine|April 18, 2022
Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver DiseaseQing-Feng Sun, Liang-Jie Tang, Ming-Jie Wang, et al.Diabetes, Obesity & Metabolism|September 17, 2024
Associations between cuprotosis-related genes and the spectrum of metabolic dysfunction-associated fatty liver disease: An exploratory studyHai-Yang Yuan, Wen-Yue Liu, Gong Feng, et al.Acta Pharmacologica Sinica|November 22, 2016
Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distributionWen-Yue Liu, Jing-Wei Zhang, Xue-Quan Yao, et al.Alimentary Pharmacology & Therapeutics|July 5, 2023
AutoFibroNet: A deep learning and multi-photon microscopy-derived automated network for liver fibrosis quantification in MAFLDHuiling Zhan, Siyu Chen, Feng Gao, et al.JCI Insight|August 8, 2022
SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surfaceNan Zhao, Xiaoxun Zhang, Jingjing Ding, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2026
Risk stratification of a novel non-invasive fibrosis score in metabolic dysfunction-associated steatotic liver diseaseJohnny T K Cheung, Xinsrong Zhang, Grace Lai-Hung Wong, et al.Alimentary Pharmacology & Therapeutics|September 19, 2023
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver diseaseJohnny T K Cheung, Xinrong Zhang, Grace Lai-Hung Wong, et al.Pageof 11